Further insights into SGLT2 inhibitors

被引：4
|
作者：
Fernandez-Ruiz, Irene
机构：
来源：
NATURE REVIEWS CARDIOLOGY | 2018年 / 15卷 / 01期
关键词：
D O I：
10.1038/nrcardio.2017.198
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [1] Further insights into SGLT2 inhibitors
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2018, 15 : 2 - 2
  • [2] SGLT2 INHIBITORS
    Brito, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E162 - E162
  • [3] SGLT2 inhibitors
    Dardi, I.
    Kouvatsos, T.
    Jabbour, S. A.
    BIOCHEMICAL PHARMACOLOGY, 2016, 101 : 27 - 39
  • [4] SGLT2 inhibitors and cancer: why further evidence is required
    Shaikh, Altamash M. Y.
    DIABETOLOGIA, 2017, 60 (12) : 2536 - 2537
  • [5] SGLT2 inhibitors
    Steyn, Lynda
    SA PHARMACEUTICAL JOURNAL, 2018, 85 (01) : 72 - 75
  • [6] SGLT2 inhibitors and cancer: why further evidence is required
    Altamash M. Y. Shaikh
    Diabetologia, 2017, 60 : 2536 - 2537
  • [7] Evolving insights into the pleiotropic cardioprotective mechanisms of SGLT2 inhibitors
    Anke C. Fender
    Dobromir Dobrev
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 589 - 592
  • [8] Evolving insights into the pleiotropic cardioprotective mechanisms of SGLT2 inhibitors
    Fender, Anke C.
    Dobrev, Dobromir
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (4) : 589 - 592
  • [9] Ketoacidosis with SGLT2 Inhibitors
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1471): : 94 - 94
  • [10] SGLT2 inhibitors and cardioprotection
    Chen, S.
    Wang, Q.
    Christodoulou, A.
    Mylonos, N.
    Bakker, D.
    Wakker, V.
    Hollmann, M. W.
    Weber, N. C.
    Coronel, R.
    Christoffels, V.
    Andreadou, I.
    Zuurbier, C. J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53
12345